Global Companion Animal Diagnostics Market was valued at USD XX Billion in the year 2021. Global Companion Animal Diagnostics Market is further estimated to grow at a CAGR of XX% from 2022 to 2030 it will reach USD XX Billion by the year 2030. The North America region holds the highest market share in 2021 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development. The Global Companion Animal Diagnostics Report 2022-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section. On the basis of Technology, the market is divided as Immunodiagnostic, Clinical Biochemistry, Hematology, Urine Analysis. In which Immunodiagnostic for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW. Market player analysis of major companies such as IDEXX Laboratories, Inc., Zoetis, Inc., Heska Corporation, Thermo Fisher Scientific, Inc., Virbac, Heska Corporation, Neogen Corporation, bioMérieux SA, IDvet, INDICAL Bioscience GmbH.

1 INTRODUCTION 1.1 OBJECTIVES 1.2 RESEARCH METHODOLOGY 1.2.1 SECONDARY DATA 1.2.2 PRIMARY DATA 1.2.3 MARKET SIZE ESTIMATION 1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 1.3 STAKEHOLDERS 1.4 RESEARCH ASSUMPTIONS 1.5 LIMITATION 2 EXECUTIVE SUMMARY 3 MARKET OUTLOOK 3.1 INTRODUCTION 3.2 OPPORTUNITIES MATRIX 3.3 MARKET CHALLENGES 3.4 MARKET SHARE ANALYSIS 3.5 VALUE CHAIN ANALYSIS 3.6 DEMAND SIDE ANALYSIS 3.7 SUPPLY SIDE ANALYSIS 3.8 PORTER’S FIVE FORCES MODEL 3.8.1 DEGREE OF COMPETITION 3.8.2 BARGAINING POWER OF BUYERS 3.8.3 BARGAINING POWER OF SUPPLIERS 3.8.4 THREAT FROM SUBSTITUTES 3.8.5 THREAT FROM NEW ENTRANTS 4 INDUSTRY TRENDS 4.1 PRODUCT LIFE CYCLE 4.2 NEW MARKET ENTRY STRATEGY 4.3 PESTEL ANALYSIS 4.4 PRICING ANALYSIS 4.5 TRADE DATA 4.6 TECHNOLOGICAL OVERVIEW 4.7 FUTURE OUTLOOK MARKET TRENDS 4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES) 4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS 4.10 REGRESSION MATRIX 4.11 COVID-19 IMPACT ANALYSES 4.12 GE MATRIX 5 COMPANION ANIMAL DIAGNOSTICS TECHNOLOGY ANALYSIS 5.1 INTRODUCTION 5.2 HISTORICAL MARKET TECHNOLOGY ANALYSIS, 2016-2020 5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030 5.4 Y-O-Y GROWTH TREND ANALYSIS 5.5 CLINICAL BIOCHEMISTRY 5.5.1 CLINICAL CHEMISTRY ANALYSIS 5.5.1.1 Clinical Chemistry Reagent Clips and Cartridges 5.5.1.2 Clinical Chemistry Analyzers 5.5.2 GLUCOSE MONITORING 5.5.2.1 Blood Glucose Strips 5.5.2.2 Glucose Monitors 5.5.2.3 Urine Glucose Strips 5.5.3 BLOOD GAS & ELECTROLYTE ANALYSIS 5.5.3.1 Blood Gas & Electrolyte Reagent Clips and Cartridges 5.5.3.2 Blood Gas & Electrolyte Analyzers 5.6 IMMUNODIAGNOSTICS 5.6.1 LATERAL FLOW ASSAYS 5.6.2 ELISA TESTS 5.6.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 5.6.4 IMMUNOASSAY ANALYZERS 5.6.5 OTHER IMMUNODIAGNOSTIC PRODUCTS (ASSAY TESTS SUCH AS AGGLUTINATION TESTS, FLUORINATED AGGLUTINATION TESTS, IMMUNOHISTOCHEMISTRY, WESTERN BLOT TESTS, NON-INFECTION IMMUNOASSAYS, COMPLEMENT FIXATION, AGAR GEL IMMUNODIFFUSION, AND SERUM/VIRUS NEUTRALIZATION) 5.7 HEMATOLOGY 5.7.1 HEMATOLOGY CARTRIDGES 5.7.2 HEMATOLOGY ANALYZERS 5.8 URINALYSIS 5.8.1 URINALYSIS CLIPS & CARTRIDGES/PANELS 5.8.2 URINE ANALYZERS 5.8.3 URINE TEST STRIPS 5.9 MOLECULAR DIAGNOSTICS 5.9.1 POLYMER CHAIN REACTION TESTS 5.9.2 MICROARRAYS 5.9.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS (DNA SEQUENCING, GENOTYPING, DNA PROFILES, AND NEXT-GENERATION SEQUENCING) 5.10 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES (MICROBIOLOGY TESTS AND HISTOPATHOLOGY TESTS) 6 COMPANION ANIMAL DIAGNOSTICS ANIMAL TYPE ANALYSIS 6.1 INTRODUCTION 6.2 HISTORICAL MARKET ANIMAL TYPE ANALYSIS, 2016-2020 6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030 6.4 Y-O-Y GROWTH TREND ANALYSIS 6.5 DOGS 6.6 CATS 6.7 HORSES 6.8 OTHER COMPANION ANIMALS (RABBITS, REPTILES, PET FISH, AND BIRDS) 7 COMPANION ANIMAL DIAGNOSTICS END USE ANALYSIS 7.1 INTRODUCTION 7.2 HISTORICAL MARKET END USE ANALYSIS, 2016-2020 7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030 7.4 Y-O-Y GROWTH TREND ANALYSIS 7.5 VETERINARY REFERENCE LABORATORIES 7.6 VETERINARY HOSPITALS AND CLINICS 7.7 POINT-OF-CARE/IN-HOUSE TESTING 7.8 RESEARCH INSTITUTES AND UNIVERSITIES 8 COMPANION ANIMAL DIAGNOSTICS MARKET APPLICATION ANALYSIS 8.1 INTRODUCTION 8.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020 8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030 8.4 Y-O-Y GROWTH TREND ANALYSIS 8.5 CLINICAL PATHOLOGY 8.6 BACTERIOLOGY 8.7 VIROLOGY 8.8 PARASITOLOGY 8.9 OTHER APPLICATIONS (PREGNANCY TESTING, GENETIC TESTING, AND TOXICOLOGY TESTING) 9 GLOBAL COMPANION ANIMAL DIAGNOSTICS REGIONAL ANALYSIS 9.1 INTRODUCTION 9.2 NORTH AMERICA 9.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020 9.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030 9.2.3 Y-O-Y GROWTH TREND ANALYSIS 9.2.3.1 U.S. 9.2.3.2 Canada 9.2.3.3 Mexico 9.3 ASIA-PACIFIC 9.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020 9.3.2 Y-O-Y GROWTH TREND ANALYSIS 9.3.2.1 China 9.3.2.2 Japan 9.3.2.3 Korea 9.3.2.4 India 9.3.2.5 Southeast Asia 9.4 MIDDLE EAST AND AFRICA 9.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020 9.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030 9.4.3 Y-O-Y GROWTH TREND ANALYSIS 9.4.3.1 Saudi Arabia 9.4.3.2 UAE 9.4.3.3 Egypt 9.4.3.4 Nigeria 9.4.3.5 South Africa 9.5 EUROPE 9.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020 9.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030 9.5.3 Y-O-Y GROWTH TREND ANALYSIS 9.5.3.1 Germany 9.5.3.2 France 9.5.3.3 UK 9.5.3.4 Russia 9.5.3.5 Italy 9.6 LATIN AMERICA 9.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020 9.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030 9.6.3 Y-O-Y GROWTH TREND ANALYSIS 9.6.3.1 Brazil 9.6.3.2 Argentina 9.6.3.3 Columbia 10 MARKET PLAYERS 10.1 IDEXX LABORATORIES, INC. 10.1.1 BUSINESS OVERVIEW: 10.1.2 PRODUCT PORTFOLIO 10.1.3 RECENT DEVELOPMENTS 10.1.4 SWOT ANALYSIS: 10.2 ZOETIS, INC. 10.3 HESKA CORPORATION 10.4 THERMO FISHER SCIENTIFIC, INC. 10.5 VIRBAC 10.6 HESKA CORPORATION 10.7 NEOGEN CORPORATION 10.8 BIOMÉRIEUX SA 10.9 IDVET 10.10 INDICAL BIOSCIENCE GMBH 11 ABOUT US

TABLE 1 COMPANION ANIMAL DIAGNOSTICS REGIONAL ANALYSIS, 2021–2030 (USD MILLION) TABLE 2 GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, 2021–2030, (USD MILLION) TABLE 3 COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE REGIONAL ANALYSIS, 2021–2030 (USD MILLION) TABLE 4 GLOBAL COMPANION ANIMAL DIAGNOSTICS HISTORICAL MARKET TECHNOLOGY ANALYSIS, 2016-2020, (USD MILLION) TABLE 5 COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION) TABLE 6 GLOBAL COMPANION ANIMAL DIAGNOSTICS HISTORICAL MARKET ANIMAL TYPE ANALYSIS, 2016-2020, (USD MILLION) TABLE 7 COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE ANIMAL TYPE ANALYSIS, 2021–2030 (USD MILLION) TABLE 8 GLOBAL COMPANION ANIMAL DIAGNOSTICS HISTORICAL MARKET END USE ANALYSIS, 2016-2020, (USD MILLION) TABLE 9 COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE END USE ANALYSIS, 2021–2030 (USD MILLION) TABLE 10 GLOBAL COMPANION ANIMAL DIAGNOSTICS HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020, (USD MILLION) TABLE 11 COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION) TABLE 12 NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION) TABLE 13 NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION) TABLE 14 NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE ANIMAL TYPE ANALYSIS, 2021–2030 (USD MILLION) TABLE 15 NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE END USE ANALYSIS, 2021–2030 (USD MILLION) TABLE 16 NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION) TABLE 17 U.S. COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2016–2021 TABLE 18 U.S. COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 19 U.S. COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 20 CANADA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 21 CANADA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 22 MEXICO COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 23 MEXICO COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 24 APAC COMPANION ANIMAL DIAGNOSTICS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION) TABLE 25 ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION) TABLE 26 ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE ANIMAL TYPE ANALYSIS, 2021–2030 (USD MILLION) TABLE 27 ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE END USE ANALYSIS, 2021–2030 (USD MILLION) TABLE 28 ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION) TABLE 29 CHINA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 30 CHINA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 31 JAPAN COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 32 JAPAN COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 33 KOREA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 34 KOREA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 35 INDIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 36 INDIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 37 SOUTHEAST ASIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 38 SOUTHEAST ASIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 39 MIDDLE EAST AND AFRICA COMPANION ANIMAL DIAGNOSTICS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION) TABLE 40 MIDDLE EAST AND AFRICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION) TABLE 41 MIDDLE EAST AND AFRICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE ANIMAL TYPE ANALYSIS, 2021–2030 (USD MILLION) TABLE 42 MIDDLE EAST AND AFRICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE END USE ANALYSIS, 2021–2030 (USD MILLION) TABLE 43 MIDDLE EAST AND AFRICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION) TABLE 44 SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 45 SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 46 UAE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 47 UAE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 48 EGYPT COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 49 EGYPT COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 50 NIGERIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 51 NIGERIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 52 SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 53 SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 54 EUROPE COMPANION ANIMAL DIAGNOSTICS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION) TABLE 55 EUROPE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION) TABLE 56 EUROPE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE ANIMAL TYPE ANALYSIS, 2021–2030 (USD MILLION) TABLE 57 EUROPE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE END USE ANALYSIS, 2021–2030 (USD MILLION) TABLE 58 EUROPE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION) TABLE 59 GERMANY COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 60 GERMANY COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 61 FRANCE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 62 FRANCE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 63 UK COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 64 UK COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 65 RUSSIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 66 RUSSIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 67 ITALY COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 68 ITALY COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 69 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION) TABLE 70 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030 (USD MILLION) TABLE 71 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE ANIMAL TYPE ANALYSIS, 2021–2030 (USD MILLION) TABLE 72 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE END USE ANALYSIS, 2021–2030 (USD MILLION) TABLE 73 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION) TABLE 74 BRAZIL COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 75 BRAZIL COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 76 ARGENTINA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 77 ARGENTINA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION) TABLE 78 COLUMBIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION) TABLE 79 COLUMBIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)

FIGURE 1 GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 COMPANION ANIMAL DIAGNOSTICS TECHNOLOGY ANALYSIS
FIGURE 11 GLOBAL COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE MARKET TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 COMPANION ANIMAL DIAGNOSTICS ANIMAL TYPE ANALYSIS
FIGURE 13 GLOBAL COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE MARKET ANIMAL TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 COMPANION ANIMAL DIAGNOSTICS END USE ANALYSIS
FIGURE 15 GLOBAL COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE MARKET END USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 COMPANION ANIMAL DIAGNOSTICS APPLICATION ANALYSIS
FIGURE 17 GLOBAL COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 GLOBAL COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 19 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 MARKET SHARE BY COUNTRY
FIGURE 21 NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE ANIMAL TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 23 NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE END USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 U.S. COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 U.S. COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 CANADA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 CANADA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 29 MEXICO COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 MEXICO COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 MARKET SHARE BY COUNTRY
FIGURE 32 APAC COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 APAC COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE ANIMAL TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 APAC COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE END USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 35 APAC COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 CHINA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 CHINA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 JAPAN COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 JAPAN COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 KOREA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 KOREA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 INDIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 43 INDIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 SOUTHEAST ASIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 SOUTHEAST ASIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 MARKET SHARE BY COUNTRY
FIGURE 47 MIDDLE EAST AND AFRICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 MIDDLE EAST AND AFRICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE ANIMAL TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 MIDDLE EAST AND AFRICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE END USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 MIDDLE EAST AND AFRICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 51 SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 SAUDI ARABIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 UAE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 UAE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 EGYPT COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 EGYPT COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 57 NIGERIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 NIGERIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 SOUTH AFRICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 MARKET SHARE BY COUNTRY
FIGURE 62 EUROPE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 EUROPE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE ANIMAL TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 EUROPE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE END USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 EUROPE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 GERMANY COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 67 GERMANY COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 FRANCE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 FRANCE COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 UK COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 71 UK COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 RUSSIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 RUSSIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 ITALY COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 ITALY COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 MARKET SHARE BY COUNTRY
FIGURE 77 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE ANIMAL TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE END USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 81 BRAZIL COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 82 BRAZIL COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 83 ARGENTINA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 84 ARGENTINA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 85 COLUMBIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE TECHNOLOGY ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 86 COLUMBIA COMPANION ANIMAL DIAGNOSTICS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 87 FINANCIAL OVERVIEW: